MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1573.45%
Quick Ratio
1573.45%
Cash Ratio
967.75%
Debt to Asset Ratio
3.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Long-term marketable securities
    • Cash and cash equivalents
    • Marketable securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
474,761
536,333
357,329
149,527
Marketable securities
283,790
250,532
242,002
117,630
Prepaid expenses and other current assets
13,352
10,909
11,580
6,687
Total current assets
771,903
797,774
610,911
273,844
Long-term marketable securities
615,290
660,938
326,757
122,008
Property and equipment, net
492
170
147
174
Operating lease right-of-use assets
1,001
1,320
92
362
Internal-use software
773
-
-
-
Other assets
643
-
0
0
Total assets
1,390,102
1,460,202
937,907
396,388
Accounts payable
23,386
31,158
24,628
30,819
Accrued expenses
24,585
17,648
35,033
21,628
Operating lease liabilities
1,087
1,435
110
436
Total current liabilities
49,058
50,241
59,771
52,883
Non-current portion of operating lease liabilities
-
-
0
0
Total liabilities
49,058
50,241
59,771
52,883
Common stock, 0.0001 par value 150,000,000 shares authorized 27,916,593 shares issued and outstanding as of june30, 2026, and 25,195,092 shares issued and outstanding as of december31, 2025
15
15
15
14
Additional paid-in capital
2,659,990
2,644,109
2,017,566
1,394,088
Accumulated deficit
-1,316,289
-1,232,569
-1,140,008
-1,051,097
Accumulated other comprehensive (loss) gain
-2,672
-1,594
563
500
Total stockholders equity
1,341,044
1,409,961
878,136
343,505
Total liabilities and stockholders equity
1,390,102
1,460,202
937,907
396,388
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$474,761K (201.60%↑ Y/Y)Marketable securities$283,790K (97.27%↑ Y/Y)Prepaid expenses andother current assets$13,352K (151.73%↑ Y/Y)Total current assets$771,903K (151.78%↑ Y/Y)Long-term marketablesecurities$615,290K (323.26%↑ Y/Y)Operating leaseright-of-use assets$1,001K (59.90%↑ Y/Y)Internal-use software$773K Other assets$643K Property and equipment,net$492K (90.70%↑ Y/Y)Total assets$1,390,102K (206.98%↑ Y/Y)Total liabilities andstockholders equity$1,390,102K (206.98%↑ Y/Y)Total stockholdersequity$1,341,044K (231.76%↑ Y/Y)Total liabilities$49,058K (0.93%↑ Y/Y)Accumulated deficit-$1,316,289K (-34.71%↓ Y/Y)Accumulated othercomprehensive (loss) gain-$2,672K (-776.46%↓ Y/Y)Additional paid-in capital$2,659,990K (92.62%↑ Y/Y)Total currentliabilities$49,058K (0.93%↑ Y/Y)Common stock, 0.0001par value...$15K (7.14%↑ Y/Y)Accrued expenses$24,585K (29.25%↑ Y/Y)Accounts payable$23,386K (-18.89%↓ Y/Y)Operating leaseliabilities$1,087K (43.97%↑ Y/Y)

Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines, Inc. (PRAX)